Convenient preparation of tumor-specific immunoliposomes containing doxorubicin

Journal of Biochemistry and Molecular Biology

Volumn 31, Issue 1, 1998, Pages 95-100

  Nam, Sang Min ^a   Cho, Jang Eun ^a   Son, Byoung Soo ^a   Park, Yong Serk ^a  

^a Yonsei University Wonju   (South Korea)

Author keywords

Doxorubicin; Immunoliposome; Target sensitivity

Indexed keywords

EID: 0032342619     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ahmad, I., Longenecher, M., Samuel, J., and Allen, T. M. (1993) Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53, 1484-1488.
2. Barlet, G. R. (1962) Phosphate assay in column chromatography. J. Biol. Chem. 234, 466-468.
3. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Carter, S. K. (1975) Adriamycin - a review. J. Nat'l. Cancer. Inst. 55, 1265-1274.
5. Delgado, G., Potkul, R. K., Treat, J. A., Lewandowski, G. S., Barter, J. F., Forst, D., and Rahman, A. (1989) A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. Am. J. Obstet Gynecol. 160, 812-817.
6. Derksen, J. T. P., Marselt, H. W. M., and Scherphof, G. L. (1988) Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta. 971, 127-136.
7. M3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. Cancer Res. 48, 5680-5685.
8. Gabizon, A., Dagan, A., Goren, D., Barenholz, Y., and Fuks, Z. (1982) Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 42, 4734.
9. Gregoriadis, G. (1993) Liposome Technology, Vol. I, II, III, CRC Press, Boca Ranton, Florida.
10. Hakomori, S. I. (1992) Serological Cancer Markers 207, The Humana Press, Totowa, New Jersey.
11. Maruyama, K., Kennel, S., and Huang, L. (1990) Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc. Natl. Acad. Sci. USA 87, 5744-5748.
12. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. T., Huang, L., and Iwatsuru, M. (1995) Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234, 74-80.
13. Mayer, L. D., Mayer, Linda C. L. Tai, Marcel B. Bally, and George N. Mitilenes et al., (1990) Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta 1025, 143-151.
14. Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., and Young, R. .C. (1977) Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165-167.
15. Nakasaki, H., Mitomi, T., Noto, T., Ogoshi, K., Hanaue, H., Tanaka, Y., Makuuchi, H., Clausen, H., and Hakomori, S. (1989) Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers. Cancer Res. 49, 3662-3669.
16. Olson, R. D. and Mushin P. S. (1990) Doxorubicin cardiotoxicity: analysis of prevailing hypotheses [see comments] FASEB J. 4, 3076-3086.
17. Otaka, M., Singhal, A., and Hakomori. S. (1989) Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note. Biochem. Biophys. Res. Comm. 158, 202-208.
18. M1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. Biochim. Biophys. Acta 1166, 105-114.
19. Park, Y. S. and Huang, L. (1993b) Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A. J. Drug Targeting 1, 325-330.
20. Pinnaduwage, P and Huang, L. (1992) Stable target-sensitive immunoliposomes. Biochemistry 31, 2850-2855.
21. Rahman. A., Fuamgalli, A., Barbieri, B., Schein, P. S., and Casazza, A. M. (1986) Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Chemother. Pharmachol. 16, 22-27.
22. Rahman, A., Kessler, A., More, N., Sikic, B., Rowden, G., Woolley, P., and Schein, P. S. (1980) Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 40, 1532-1537.
23. Treat, J., Greenspan, A., Forst, D., Sanchez, J. A., Ferrans, V. J., Potkul, L. A., Wooley, P. V., and Rahman, A (1990) Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J. Natl. Cancer Instit. 82, 1706-1710.
24. Vingerhoeds, M. H., Steerenberg, P. A., Hendriks, J. J. G. W., Dekker, L. C., van Hoesel, Q. G. C. M., Crommelin, D. J. A., and Storm, G (1996) Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. British J. Cancer 74, 1023-1029.
25. Young, R. C., Ozols, R. F., and Mayers, C. E. (1981) The anthracycline antineoplastic drugs. N. Engl. J. Med. 305, 139-153.